Free Trial
NASDAQ:VALN

Valneva (VALN) Stock Price, News & Analysis

Valneva logo
$8.24 +0.38 (+4.76%)
As of 02:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Valneva Stock (NASDAQ:VALN)

Key Stats

Today's Range
$7.90
$8.32
50-Day Range
$5.56
$7.87
52-Week Range
$3.62
$8.66
Volume
70,958 shs
Average Volume
59,234 shs
Market Capitalization
$701.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50
Consensus Rating
Buy

Company Overview

Valneva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

VALN MarketRank™: 

Valneva scored higher than 54% of companies evaluated by MarketBeat, and ranked 952nd out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Valneva has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Valneva has only been the subject of 1 research reports in the past 90 days.

  • Read more about Valneva's stock forecast and price target.
  • Earnings Growth

    Earnings for Valneva are expected to decrease in the coming year, from $0.13 to ($0.97) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Valneva is -6.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Valneva is -6.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Valneva has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Valneva's valuation and earnings.
  • Percentage of Shares Shorted

    0.03% of the float of Valneva has been sold short.
  • Short Interest Ratio / Days to Cover

    Valneva has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Valneva has recently decreased by 99.97%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Valneva does not currently pay a dividend.

  • Dividend Growth

    Valneva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.03% of the float of Valneva has been sold short.
  • Short Interest Ratio / Days to Cover

    Valneva has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Valneva has recently decreased by 99.97%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Valneva has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Valneva this week, compared to 4 articles on an average week.
  • Search Interest

    1 people have searched for VALN on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Valneva to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Valneva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.91% of the stock of Valneva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 11.39% of the stock of Valneva is held by institutions.

  • Read more about Valneva's insider trading history.
Receive VALN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valneva and its competitors with MarketBeat's FREE daily newsletter.

VALN Stock News Headlines

VALNEVA Declaration of shares and voting rights: July 31, 2025
Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks
What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strategy: Sell This, Buy That. In his newest presentation, Eric reveals 7 new trade ideas—pairing overhyped, vulnerable stocks with lesser-known opportunities showing real upside. These contrarian picks come from the same approach that helped him beat Wall Street legends 10-to-1 in Portfolios with Purpose.
See More Headlines

VALN Stock Analysis - Frequently Asked Questions

Valneva's stock was trading at $4.37 at the beginning of the year. Since then, VALN shares have increased by 89.9% and is now trading at $8.30.

Valneva SE Sponsored ADR (NASDAQ:VALN) issued its earnings results on Wednesday, May, 7th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.40) by $0.27. The business had revenue of $51.79 million for the quarter, compared to analyst estimates of $41.80 million. Valneva had a negative trailing twelve-month return on equity of 43.05% and a negative net margin of 43.08%.
Read the conference call transcript
.

Valneva (VALN) raised $99 million in an initial public offering (IPO) on Thursday, May 6th 2021. The company issued 3,500,000 shares at $28.24 per share. Goldman Sachs, Jefferies, Guggenheim Securities and Bryan, Garnier & Co. served as the underwriters for the IPO.

Shares of VALN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Valneva investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/07/2025
Today
8/06/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VALN
CIK
1836564
Fax
N/A
Employees
700
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$14.00
Potential Upside/Downside
+97.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
60.54
P/E Growth
N/A
Net Income
-$13.25 million
Net Margins
-43.08%
Pretax Margin
-6.77%
Return on Equity
-43.05%
Return on Assets
-16.23%

Debt

Debt-to-Equity Ratio
0.92
Current Ratio
2.70
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$183.52 million
Price / Sales
3.65
Cash Flow
$0.10 per share
Price / Cash Flow
76.76
Book Value
$2.41 per share
Price / Book
3.27

Miscellaneous

Outstanding Shares
85,090,000
Free Float
72,406,000
Market Cap
$669.66 million
Optionable
Not Optionable
Beta
1.77

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:VALN) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners